Evidence map›Paper›PMID 18045946›Full record

ArticleJournal of virology2008

Gamma/Delta T-cell functional responses differ after pathogenic human immunodeficiency virus and nonpathogenic simian immunodeficiency virus infections.

David A Kosub, Ginger Lehrman, Jeffrey M Milush, Dejiang Zhou, Elizabeth Chacko, Amanda Leone, Shari Gordon, Guido Silvestri, James G Else, Philip Keiser and 2 more

Abstract readComparative Study
In one paragraph

Article in Journal of virology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Boosting the Immune System for HIV Cure: A γδ T Cell Perspective.Frontiers in cellular and infection microbiology · 2020
    Review
  9. Article
  10. High Activation of γδ T Cells and the γδ2Frontiers in immunology · 2019
    Article
  11. Article
  12. Review
  13. Gut-homing Δ42PD1Nature microbiology · 2017
    Article
  14. Article
  15. Article
  16. Article
  17. Loss of Intra-Epithelial Endocervical Gamma Delta (GD) 1 T Cells in HIV-Infected Women.American journal of reproductive immunology (New York, N.Y. : 1989) · 2016
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

David A KosubSeattle Biomedical Research Institute, 307 Westlake Ave. N., Seattle, WA 98109, USA.
Ginger Lehrman
Jeffrey M Milush
Dejiang Zhou
Elizabeth Chacko
Amanda Leone
Shari Gordon
Guido Silvestri
James G Else
Philip Keiser
Mamta K Jain
Donald L Sodora

Funding

YNPRC NHP CLINICAL MEDICINE RESIDENCY PROGRAM - SUPPLEMENTP51RR000165 · NCRR · EMORY UNIVERSITY · PI ALTMAN, JOHN DAVID · 1985 to 2011
$114.0M
INTEGRATIVE IMMUNOLOGY TRAINING PROGRAMT32AI005284 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI Nan Yan · 2003 to 2026
$7.4M
Factors Influencing Oral Transmission of SIVR01DE017541 · NIDCR · SEATTLE BIOMEDICAL RESEARCH INSTITUTE · PI SODORA, DONALD L · 2007 to 2010
$3.0M
VIROLOGY AND IMMUNOLOGY OF ACUTE HIV1 INFECTIONR01AI035522 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI PETERSON, DOLORES MURL · 1994 to 2006
$2.7M
Viral Cytopathicity in CD4-Low SIV Passaged MangabeysR21AI060451 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI PETERSON, DOLORES MURL · 2005 to 2006
$530k
NCRR NIH HHS P51 RR000165NCRR NIH HHS RR00165NIAID NIH HHS 5T32 AI005284NIAID NIH HHS R01 AI035522NIAID NIH HHS R01-AI035522NIAID NIH HHS R21 AI060451NIAID NIH HHS R21-AI060451NIAID NIH HHS T32 AI005284
6 · The paper itself

Abstract

The objective of this study was to functionally assess gamma/delta (gammadelta) T cells following pathogenic human immunodeficiency virus (HIV) infection of humans and nonpathogenic simian immunodeficiency virus (SIV) infection of sooty mangabeys. gammadelta T cells were obtained from peripheral blood samples from patients and sooty mangabeys that exhibited either a CD4-healthy (>200 CD4(+) T cells/mul blood) or CD4-low (<200 CD4 cells/mul blood) phenotype. Cytokine flow cytometry was utilized to assess production of Th1 cytokines tumor necrosis factor alpha and gamma interferon following ex vivo stimulation with either phorbol myristate acetate/ionomycin or the Vdelta2 gammadelta T-cell receptor agonist isopentenyl pyrophosphate. Sooty mangabeys were observed to have higher percentages of gammadelta T cells in their peripheral blood than humans did. Following stimulation, gammadelta T cells from SIV-positive (SIV(+)) mangabeys maintained or increased their ability to express the Th1 cytokines regardless of CD4(+) T-cell levels. In contrast, HIV-positive (HIV(+)) patients exhibited a decreased percentage of gammadelta T cells expressing Th1 cytokines following stimulation. This dysfunction is primarily within the Vdelta2(+) gammadelta T-cell subset which incurred both a decreased overall level in the blood and a reduced Th1 cytokine production. Patients treated with highly active antiretroviral therapy exhibited a partial restoration in their gammadelta T-cell Th1 cytokine response that was intermediate between the responses of the uninfected and HIV(+) patients. The SIV(+) sooty mangabey natural hosts, which do not proceed to clinical AIDS, provide evidence that gammadelta T-cell dysfunction occurs in HIV(+) patients and may contribute to HIV disease progression.

Indexed as

AdultAnimalsCD4 Lymphocyte CountCells, CulturedCercocebus atysFlow CytometryHIVHIV InfectionsHumansInterferon-gammaLentivirus InfectionsMiddle AgedReceptors, Antigen, T-Cell, gamma-deltaSimian Immunodeficiency VirusT-Lymphocyte SubsetsTumor Necrosis Factor-alphaInterferon-gammaReceptors, Antigen, T-Cell, gamma-deltaTumor Necrosis Factor-alpha

Identifiers

PMID18045946
PMCPMC2224435

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.